Danegaptide (GAP-134) is a synthetic peptide acting as a ghrelin receptor agonist, investigated primarily for its role in appetite regulation and the treatment of obesity and related metabolic disorders.… Read more
Danegaptide (GAP-134) is a synthetic peptide acting as a ghrelin receptor agonist, investigated primarily for its role in appetite regulation and the treatment of obesity and related metabolic disorders. This category encompasses the parent drug alongside its stable isotope labelled derivatives, such as Danegaptide-d5, which are essential tools for modern pharmaceutical analysis. Research and quality control laboratories utilize these high-quality reference standards to develop and validate robust analytical methods, including liquid chromatography-mass spectrometry (LC-MS) assays. By serving as internal standards in pharmacokinetic studies, stable isotope labelled compounds allow for precise quantification of the drug in complex biological matrices. Furthermore, these compounds are critical for impurity profiling and ensuring strict adherence to quality control protocols, helping chemists accurately assess the identity, purity, and stability of Danegaptide throughout the drug development lifecycle.